These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

219 related items for PubMed ID: 8383214

  • 1. Identification of proteolytic processing sites within the Gag and Pol polyproteins of feline immunodeficiency virus.
    Elder JH, Schnölzer M, Hasselkus-Light CS, Henson M, Lerner DA, Phillips TR, Wagaman PC, Kent SB.
    J Virol; 1993 Apr; 67(4):1869-76. PubMed ID: 8383214
    [Abstract] [Full Text] [Related]

  • 2. Structural elements in the Gag polyprotein of feline immunodeficiency virus involved in Gag self-association and assembly.
    Abdusetir Cerfoglio JC, González SA, Affranchino JL.
    J Gen Virol; 2014 Sep; 95(Pt 9):2050-2059. PubMed ID: 24854000
    [Abstract] [Full Text] [Related]

  • 3. Extended nucleocapsid protein is cleaved from the Gag-Pol precursor of human immunodeficiency virus type 1.
    Chen N, Morag A, Almog N, Blumenzweig I, Dreazin O, Kotler M.
    J Gen Virol; 2001 Mar; 82(Pt 3):581-590. PubMed ID: 11172099
    [Abstract] [Full Text] [Related]

  • 4. Immunological characterization of the gag gene products of bovine immunodeficiency virus.
    Battles JK, Hu MY, Rasmussen L, Tobin GJ, Gonda MA.
    J Virol; 1992 Dec; 66(12):6868-77. PubMed ID: 1331499
    [Abstract] [Full Text] [Related]

  • 5. Altered Rous sarcoma virus Gag polyprotein processing and its effects on particle formation.
    Xiang Y, Ridky TW, Krishna NK, Leis J.
    J Virol; 1997 Mar; 71(3):2083-91. PubMed ID: 9032340
    [Abstract] [Full Text] [Related]

  • 6. Analysis of cleavage site mutations between the NC and PR Gag domains of Rous sarcoma virus.
    Schatz G, Pichova I, Vogt VM.
    J Virol; 1997 Jan; 71(1):444-50. PubMed ID: 8985369
    [Abstract] [Full Text] [Related]

  • 7. Naturally occurring amino acid polymorphisms in human immunodeficiency virus type 1 (HIV-1) Gag p7(NC) and the C-cleavage site impact Gag-Pol processing by HIV-1 protease.
    Goodenow MM, Bloom G, Rose SL, Pomeroy SM, O'Brien PO, Perez EE, Sleasman JW, Dunn BM.
    Virology; 2002 Jan 05; 292(1):137-49. PubMed ID: 11878916
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Mutational analysis of a native substrate of the human immunodeficiency virus type 1 proteinase.
    Partin K, Kräusslich HG, Ehrlich L, Wimmer E, Carter C.
    J Virol; 1990 Aug 05; 64(8):3938-47. PubMed ID: 2196384
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Analyses of the requirements for the synthesis of virus-like particles by feline immunodeficiency virus gag using baculovirus vectors.
    Morikawa S, Booth TF, Bishop DH.
    Virology; 1991 Jul 05; 183(1):288-97. PubMed ID: 1647071
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Altered gag polyprotein cleavage specificity of feline immunodeficiency virus/human immunodeficiency virus mutant proteases as demonstrated in a cell-based expression system.
    Lin YC, Brik A, de Parseval A, Tam K, Torbett BE, Wong CH, Elder JH.
    J Virol; 2006 Aug 05; 80(16):7832-43. PubMed ID: 16873240
    [Abstract] [Full Text] [Related]

  • 15. Extensive regions of pol are required for efficient human immunodeficiency virus polyprotein processing and particle maturation.
    Quillent C, Borman AM, Paulous S, Dauguet C, Clavel F.
    Virology; 1996 May 01; 219(1):29-36. PubMed ID: 8623542
    [Abstract] [Full Text] [Related]

  • 16. Identification of the protease cleavage sites in a reconstituted Gag polyprotein of an HERV-K(HML-2) element.
    George M, Schwecke T, Beimforde N, Hohn O, Chudak C, Zimmermann A, Kurth R, Naumann D, Bannert N.
    Retrovirology; 2011 May 09; 8():30. PubMed ID: 21554716
    [Abstract] [Full Text] [Related]

  • 17. Proteolytic activity of novel human immunodeficiency virus type 1 proteinase proteins from a precursor with a blocking mutation at the N terminus of the PR domain.
    Zybarth G, Kräusslich HG, Partin K, Carter C.
    J Virol; 1994 Jan 09; 68(1):240-50. PubMed ID: 8254734
    [Abstract] [Full Text] [Related]

  • 18. Efficient particle formation can occur if the matrix domain of human immunodeficiency virus type 1 Gag is substituted by a myristylation signal.
    Lee PP, Linial ML.
    J Virol; 1994 Oct 09; 68(10):6644-54. PubMed ID: 7521919
    [Abstract] [Full Text] [Related]

  • 19. Proteolytic cleavage at the Gag-Pol junction in avian leukosis virus: differences in vitro and in vivo.
    Stewart L, Vogt VM.
    Virology; 1994 Oct 09; 204(1):45-59. PubMed ID: 7522375
    [Abstract] [Full Text] [Related]

  • 20. Natural variation in HIV-1 protease, Gag p7 and p6, and protease cleavage sites within gag/pol polyproteins: amino acid substitutions in the absence of protease inhibitors in mothers and children infected by human immunodeficiency virus type 1.
    Barrie KA, Perez EE, Lamers SL, Farmerie WG, Dunn BM, Sleasman JW, Goodenow MM.
    Virology; 1996 May 15; 219(2):407-16. PubMed ID: 8638406
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.